Flutiform fluticasone/formoterol regulatory update

SkyePharma submitted an NDA to FDA for Flutiform fluticasone/formoterol for the maintenance treatment of asthma in patients ages 12 and older. Abbott has U.S. rights to the fixed-dose combination of f...